The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being ...

A test for pee-based markers of prostate cancer has previously relied on an uncomfortable first step. A new study has ...

Regular seeing foamy urine could signify several different health ailments, all of which need to be treated by a doctor.

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring. Late detection often requires major surgeries such as ...

Generally speaking, you will remove a test strip from the packaging and dip it into a urine sample for 10 to 15 seconds. The test will produce results in minutes. How results are displayed may vary by ...

Using existing ultrasound equipment instead of expensive MRI scanners, the test could lead to early prostate cancer detection and prove to be cost-effective for patients. The new technique has ...

However, the urine dipstick test may not be as accurate. Talk with your healthcare provider about the urine test. Normal results of a urine test called the urine albumin-creatinine ratio (uACR) fall ...

While there is no strong scientific evidence to prove that a pregnancy test with salt and urine is accurate, it is much cheaper than the commercial kits because everyone has a bit of salt in their ...

Australia will have the chance to defend their World Test Championship crown, claiming victory over India in the fifth and final Border-Gavaskar Test to secure their place in the Final at Lord's in ...

This is welcome news since the dip is in the desired direction ... a preimplantation genetic diagnosis test is carried out to check the embryo for genetic disorders. But it also determines — and is ...

Moreover, I'll explore if now is an opportunity to buy the dip, or run for the hills. On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of its new GLP-1 candidates ...